University of Missouri
Columbia, Missouri, 65211, United States
Location status: Recruiting
Location contact
Jill Kanaley, PhD
CONTACT
Jill Kanaley, PhD
PRINCIPAL_INVESTIGATOR
Matt McDonald, MS
CONTACT
NCT Number: NCT06791837
Cerebral blood flow (CBF) is essential for maintaining brain health and function, as it ensures delivery oxygen and nutrients necessary to support neuronal activity. Reduced CBF can impair the brain's ability to meet its metabolic demands, leading to deficits in cognitive ability. Impairments in CBF are associated with cognitive decline and neurodegenerative disease such as Alzheimer's and dementia. Many factors influence CBF, but recently lactate has emerged as a key player. Blood glucose has long been considered the primary fuel for the brain, but emerging evidence indicates that lactate may be the preferred fuel for neurons, and lactate may become even more important under stressful conditions.
Individuals with obesity often have impaired lactate metabolism resulting in higher resting blood lactate concentrations and reduced ability to clear lactate after a physiological stress. At the same time, it is known that exercise is a powerful intervention for improving lactate metabolism.
Thus, this project seeks to investigate the role of lactate in brain blood flow in individuals with and without obesity as well as establish if short term exercise training (individuals with obesity only) will alter circulating lactate concentrations at rest and in response to exercise.
Interested in participating?
Request Info18 year–45 year
All sexes
Observational
Columbia, Missouri, 65211, United States
Location status: Recruiting
Jill Kanaley, PhD
CONTACT
Jill Kanaley, PhD
PRINCIPAL_INVESTIGATOR
Matt McDonald, MS
CONTACT
Blood lactate is often considered a waste product from aerobic metabolism. Many people assume it causes fatigue and muscle. Lactate is a signaling molecule in the body. In addition lactate is also a fuel. Evidence supports that lactate may be more important when the brain is stressed. We also know that individuals with obesity and/or type 2 diabetes may have impaired lactate metabolism.
The investigators will compare brain blood flow and lactate response to an exercise stress test and submaximal exercise in obese and non-obese individuals.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
healthy adult men and women 18-45 years of age BMI 18-40 kg/m2 not pregnant, premenopausal with regular menstrual cycles not breastfeeding non-nicotine users
Exclusion criteria
medications known to affect sleep, autonomic control, blood lactate levels or metabolic, or cardiovascular function (PI discretion) self-reported history of hepatic, renal, pulmonary, cardiovascular, or neurological disease, stroke or neurovascular disease, bleeding/clotting disorders, sleep apnea or other sleep disorders, diabetes, history of alcoholism or substance abuse major cardiovascular event or surgical procedure within the past three months hypertension (>140/90 mmHg or at PIs discretion).
-
each group will undergo a max test and a submaximal exercise test
Time frame: over the 30 minutes of testing
Using transcranial doppler we will measure brain blood flow
Time frame: over ~ 60 minutes of testing
Lactate will be measured in response to an exercise stress test as well as to a submaximal exercise bout
Contact information is provided by the study sponsor or research team.
Jill Kanaley, PhD
CONTACT
Matt McDonald, MS
CONTACT
University of Missouri-Columbia
Other
Cerebral Lactate Uptake and Transport in Obese and Non-Obese Individuals
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01809288
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT02925156
Behavior, Body Weight
Maywood, Illinois, United States
View Trial DetailsNCT04663685
Arthritis, Behavior
Waterloo, Canada
View Trial DetailsNCT03084822
Behavior, Body Weight
View Trial Details